Results 21 to 30 of about 334,131 (356)

Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia

open access: yesFrontiers in Pharmacology, 2021
Myocardial ischemia (MI) is one of the most common cardiovascular diseases with high incidence and mortality. Huang-Lian-Jie-Du-Tang (HLJDT) is a classic traditional Chinese prescription to clear “heat” and “poison”.
Li Li   +8 more
doaj   +1 more source

TCM‐Suite: A comprehensive and holistic platform for Traditional Chinese Medicine component identification and network pharmacology analysis

open access: yesiMeta, 2022
DNA‐based biological ingredient identification and downstream pharmacology network analysis are commonly used in research for Traditional Chinese Medicine preparations (TCM formulas).
Pengshuo Yang   +8 more
doaj   +1 more source

Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19

open access: yesFrontiers in Pharmacology, 2022
Network pharmacology was rapidly developed based on multidisciplinary holistic analysis of biological systems, which has become a popular tool in traditional Chinese medicine (TCM) research in recent years.
Shihao Zheng   +5 more
doaj   +1 more source

Personalized medicine : the impact on chemistry [PDF]

open access: yes, 2010
An effective strategy for personalized medicine requires a major conceptual change in the development and application of therapeutics. In this article, we argue that further advances in this field should be made with reference to another conceptual shift,
Marsh, Andrew   +3 more
core   +1 more source

A network inference method for large-scale unsupervised identification of novel drug-drug interactions [PDF]

open access: yes, 2013
Characterizing interactions between drugs is important to avoid potentially harmful combinations, to reduce off-target effects of treatments and to fight antibiotic resistant pathogens, among others.
Guimera, Roger, Sales-Pardo, Marta
core   +8 more sources

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer's Precision Medicine and Pharmacology. [PDF]

open access: yes, 2019
Systems biology studies have demonstrated that different (epi)genetic and pathophysiological alterations may be mapped onto a single tumor's clinical phenotype thereby revealing commonalities shared by cancers with divergent phenotypes.
Goetzl, Edward J   +4 more
core   +2 more sources

A visual analysis of network pharmacology research trends

open access: yesWorld Journal of Traditional Chinese Medicine, 2018
Objective: To understand the current situation of network pharmacology, and to analyze external and internal characteristics of literature, is of great significance for the development of network pharmacology in the future and its application in the ...
Shen Xiao   +8 more
doaj   +1 more source

Best practices to maximize the use and reuse of quantitative and systems pharmacology models: recommendations from the United Kingdom quantitative and systems pharmacology network [PDF]

open access: yes, 2018
The lack of standardization in the way that quantitative and systems pharmacology (QSP) models are developed, tested, and documented hinders their reproducibility, reusability, and expansion or reduction to alternative contexts.
Amy Cheung, S. Y.   +12 more
core   +3 more sources

How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias [PDF]

open access: yes, 2020
Several pharmacoepidemiology networks have been developed over the past decade that use a distributed approach, implementing the same analysis at multiple data sites, to preserve privacy and minimize data sharing.
Brown, Jeffrey S.   +5 more
core   +2 more sources

The Complex Structure of the Pharmacological Drug–Disease Network [PDF]

open access: yesEntropy, 2021
The complexity of drug–disease interactions is a process that has been explained in terms of the need for new drugs and the increasing cost of drug development, among other factors. Over the last years, diverse approaches have been explored to understand drug–disease relationships. Here, we construct a bipartite graph in terms of active ingredients and
Irene López-Rodríguez   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy